Anti-Peptic Ulcer Drugs Market - Global Outlook and Forecast 2024-2031

Report ID: 1030249 | Published Date: Jan 2025 | No. of Page: 70 | Base Year: 2024 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Anti-Peptic Ulcer Drugs Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Anti-Peptic Ulcer Drugs Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Anti-Peptic Ulcer Drugs Overall Market Size
    2.1 Global Anti-Peptic Ulcer Drugs Market Size: 2021 VS 2028
    2.2 Global Anti-Peptic Ulcer Drugs Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Anti-Peptic Ulcer Drugs Players in Global Market
    3.2 Top Global Anti-Peptic Ulcer Drugs Companies Ranked by Revenue
    3.3 Global Anti-Peptic Ulcer Drugs Revenue by Companies
    3.4 Top 3 and Top 5 Anti-Peptic Ulcer Drugs Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Anti-Peptic Ulcer Drugs Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Anti-Peptic Ulcer Drugs Players in Global Market
        3.6.1 List of Global Tier 1 Anti-Peptic Ulcer Drugs Companies
        3.6.2 List of Global Tier 2 and Tier 3 Anti-Peptic Ulcer Drugs Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Anti-Peptic Ulcer Drugs Market Size Markets, 2021 & 2028
        4.1.2 Proton Pump Inhibitors (PPIs)
        4.1.3 Potassium-Competitive Acid Blockers (P-CAB)
        4.1.4 Antacids
        4.1.5 H2 Antagonists
        4.1.6 Ulcer Protective Drugs
    4.2 By Type - Global Anti-Peptic Ulcer Drugs Revenue & Forecasts
        4.2.1 By Type - Global Anti-Peptic Ulcer Drugs Revenue, 2017-2022
        4.2.2 By Type - Global Anti-Peptic Ulcer Drugs Revenue, 2023-2028
        4.2.3 By Type - Global Anti-Peptic Ulcer Drugs Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Anti-Peptic Ulcer Drugs Market Size, 2021 & 2028
        5.1.2 Gastritis
        5.1.3 Gastric Ulcers
        5.1.4 Duodenal Ulcers
        5.1.5 Gastroesophageal Reflux Disease (GERD)
    5.2 By Application - Global Anti-Peptic Ulcer Drugs Revenue & Forecasts
        5.2.1 By Application - Global Anti-Peptic Ulcer Drugs Revenue, 2017-2022
        5.2.2 By Application - Global Anti-Peptic Ulcer Drugs Revenue, 2023-2028
        5.2.3 By Application - Global Anti-Peptic Ulcer Drugs Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Anti-Peptic Ulcer Drugs Market Size, 2021 & 2028
    6.2 By Region - Global Anti-Peptic Ulcer Drugs Revenue & Forecasts
        6.2.1 By Region - Global Anti-Peptic Ulcer Drugs Revenue, 2017-2022
        6.2.2 By Region - Global Anti-Peptic Ulcer Drugs Revenue, 2023-2028
        6.2.3 By Region - Global Anti-Peptic Ulcer Drugs Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Anti-Peptic Ulcer Drugs Revenue, 2017-2028
        6.3.2 US Anti-Peptic Ulcer Drugs Market Size, 2017-2028
        6.3.3 Canada Anti-Peptic Ulcer Drugs Market Size, 2017-2028
        6.3.4 Mexico Anti-Peptic Ulcer Drugs Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Anti-Peptic Ulcer Drugs Revenue, 2017-2028
        6.4.2 Germany Anti-Peptic Ulcer Drugs Market Size, 2017-2028
        6.4.3 France Anti-Peptic Ulcer Drugs Market Size, 2017-2028
        6.4.4 U.K. Anti-Peptic Ulcer Drugs Market Size, 2017-2028
        6.4.5 Italy Anti-Peptic Ulcer Drugs Market Size, 2017-2028
        6.4.6 Russia Anti-Peptic Ulcer Drugs Market Size, 2017-2028
        6.4.7 Nordic Countries Anti-Peptic Ulcer Drugs Market Size, 2017-2028
        6.4.8 Benelux Anti-Peptic Ulcer Drugs Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Anti-Peptic Ulcer Drugs Revenue, 2017-2028
        6.5.2 China Anti-Peptic Ulcer Drugs Market Size, 2017-2028
        6.5.3 Japan Anti-Peptic Ulcer Drugs Market Size, 2017-2028
        6.5.4 South Korea Anti-Peptic Ulcer Drugs Market Size, 2017-2028
        6.5.5 Southeast Asia Anti-Peptic Ulcer Drugs Market Size, 2017-2028
        6.5.6 India Anti-Peptic Ulcer Drugs Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Anti-Peptic Ulcer Drugs Revenue, 2017-2028
        6.6.2 Brazil Anti-Peptic Ulcer Drugs Market Size, 2017-2028
        6.6.3 Argentina Anti-Peptic Ulcer Drugs Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Anti-Peptic Ulcer Drugs Revenue, 2017-2028
        6.7.2 Turkey Anti-Peptic Ulcer Drugs Market Size, 2017-2028
        6.7.3 Israel Anti-Peptic Ulcer Drugs Market Size, 2017-2028
        6.7.4 Saudi Arabia Anti-Peptic Ulcer Drugs Market Size, 2017-2028
        6.7.5 UAE Anti-Peptic Ulcer Drugs Market Size, 2017-2028
7 Players Profiles
    7.1 AstraZeneca
        7.1.1 AstraZeneca Corporate Summary
        7.1.2 AstraZeneca Business Overview
        7.1.3 AstraZeneca Anti-Peptic Ulcer Drugs Major Product Offerings
        7.1.4 AstraZeneca Anti-Peptic Ulcer Drugs Revenue in Global Market (2017-2022)
        7.1.5 AstraZeneca Key News
    7.2 Ask-pharm
        7.2.1 Ask-pharm Corporate Summary
        7.2.2 Ask-pharm Business Overview
        7.2.3 Ask-pharm Anti-Peptic Ulcer Drugs Major Product Offerings
        7.2.4 Ask-pharm Anti-Peptic Ulcer Drugs Revenue in Global Market (2017-2022)
        7.2.5 Ask-pharm Key News
    7.3 Takeda
        7.3.1 Takeda Corporate Summary
        7.3.2 Takeda Business Overview
        7.3.3 Takeda Anti-Peptic Ulcer Drugs Major Product Offerings
        7.3.4 Takeda Anti-Peptic Ulcer Drugs Revenue in Global Market (2017-2022)
        7.3.5 Takeda Key News
    7.4 Yangtze River Pharm
        7.4.1 Yangtze River Pharm Corporate Summary
        7.4.2 Yangtze River Pharm Business Overview
        7.4.3 Yangtze River Pharm Anti-Peptic Ulcer Drugs Major Product Offerings
        7.4.4 Yangtze River Pharm Anti-Peptic Ulcer Drugs Revenue in Global Market (2017-2022)
        7.4.5 Yangtze River Pharm Key News
    7.5 Shandong Luoxin
        7.5.1 Shandong Luoxin Corporate Summary
        7.5.2 Shandong Luoxin Business Overview
        7.5.3 Shandong Luoxin Anti-Peptic Ulcer Drugs Major Product Offerings
        7.5.4 Shandong Luoxin Anti-Peptic Ulcer Drugs Revenue in Global Market (2017-2022)
        7.5.5 Shandong Luoxin Key News
    7.6 Huadong Medicine
        7.6.1 Huadong Medicine Corporate Summary
        7.6.2 Huadong Medicine Business Overview
        7.6.3 Huadong Medicine Anti-Peptic Ulcer Drugs Major Product Offerings
        7.6.4 Huadong Medicine Anti-Peptic Ulcer Drugs Revenue in Global Market (2017-2022)
        7.6.5 Huadong Medicine Key News
    7.7 Changzhou Siyao
        7.7.1 Changzhou Siyao Corporate Summary
        7.7.2 Changzhou Siyao Business Overview
        7.7.3 Changzhou Siyao Anti-Peptic Ulcer Drugs Major Product Offerings
        7.7.4 Changzhou Siyao Anti-Peptic Ulcer Drugs Revenue in Global Market (2017-2022)
        7.7.5 Changzhou Siyao Key News
    7.8 Beijing Yuekang
        7.8.1 Beijing Yuekang Corporate Summary
        7.8.2 Beijing Yuekang Business Overview
        7.8.3 Beijing Yuekang Anti-Peptic Ulcer Drugs Major Product Offerings
        7.8.4 Beijing Yuekang Anti-Peptic Ulcer Drugs Revenue in Global Market (2017-2022)
        7.8.5 Beijing Yuekang Key News
    7.9 Guangdong Dahua
        7.9.1 Guangdong Dahua Corporate Summary
        7.9.2 Guangdong Dahua Business Overview
        7.9.3 Guangdong Dahua Anti-Peptic Ulcer Drugs Major Product Offerings
        7.9.4 Guangdong Dahua Anti-Peptic Ulcer Drugs Revenue in Global Market (2017-2022)
        7.9.5 Guangdong Dahua Key News
    7.10 Xian Janssen
        7.10.1 Xian Janssen Corporate Summary
        7.10.2 Xian Janssen Business Overview
        7.10.3 Xian Janssen Anti-Peptic Ulcer Drugs Major Product Offerings
        7.10.4 Xian Janssen Anti-Peptic Ulcer Drugs Revenue in Global Market (2017-2022)
        7.10.5 Xian Janssen Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Anti-Peptic Ulcer Drugs Market Opportunities & Trends in Global Market
    Table 2. Anti-Peptic Ulcer Drugs Market Drivers in Global Market
    Table 3. Anti-Peptic Ulcer Drugs Market Restraints in Global Market
    Table 4. Key Players of Anti-Peptic Ulcer Drugs in Global Market
    Table 5. Top Anti-Peptic Ulcer Drugs Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Anti-Peptic Ulcer Drugs Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Anti-Peptic Ulcer Drugs Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Anti-Peptic Ulcer Drugs Product Type
    Table 9. List of Global Tier 1 Anti-Peptic Ulcer Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Anti-Peptic Ulcer Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Anti-Peptic Ulcer Drugs Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Anti-Peptic Ulcer Drugs Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Anti-Peptic Ulcer Drugs Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Anti-Peptic Ulcer Drugs Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Anti-Peptic Ulcer Drugs Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Anti-Peptic Ulcer Drugs Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2023-2028
    Table 30. AstraZeneca Corporate Summary
    Table 31. AstraZeneca Anti-Peptic Ulcer Drugs Product Offerings
    Table 32. AstraZeneca Anti-Peptic Ulcer Drugs Revenue (US$, Mn), (2017-2022)
    Table 33. Ask-pharm Corporate Summary
    Table 34. Ask-pharm Anti-Peptic Ulcer Drugs Product Offerings
    Table 35. Ask-pharm Anti-Peptic Ulcer Drugs Revenue (US$, Mn), (2017-2022)
    Table 36. Takeda Corporate Summary
    Table 37. Takeda Anti-Peptic Ulcer Drugs Product Offerings
    Table 38. Takeda Anti-Peptic Ulcer Drugs Revenue (US$, Mn), (2017-2022)
    Table 39. Yangtze River Pharm Corporate Summary
    Table 40. Yangtze River Pharm Anti-Peptic Ulcer Drugs Product Offerings
    Table 41. Yangtze River Pharm Anti-Peptic Ulcer Drugs Revenue (US$, Mn), (2017-2022)
    Table 42. Shandong Luoxin Corporate Summary
    Table 43. Shandong Luoxin Anti-Peptic Ulcer Drugs Product Offerings
    Table 44. Shandong Luoxin Anti-Peptic Ulcer Drugs Revenue (US$, Mn), (2017-2022)
    Table 45. Huadong Medicine Corporate Summary
    Table 46. Huadong Medicine Anti-Peptic Ulcer Drugs Product Offerings
    Table 47. Huadong Medicine Anti-Peptic Ulcer Drugs Revenue (US$, Mn), (2017-2022)
    Table 48. Changzhou Siyao Corporate Summary
    Table 49. Changzhou Siyao Anti-Peptic Ulcer Drugs Product Offerings
    Table 50. Changzhou Siyao Anti-Peptic Ulcer Drugs Revenue (US$, Mn), (2017-2022)
    Table 51. Beijing Yuekang Corporate Summary
    Table 52. Beijing Yuekang Anti-Peptic Ulcer Drugs Product Offerings
    Table 53. Beijing Yuekang Anti-Peptic Ulcer Drugs Revenue (US$, Mn), (2017-2022)
    Table 54. Guangdong Dahua Corporate Summary
    Table 55. Guangdong Dahua Anti-Peptic Ulcer Drugs Product Offerings
    Table 56. Guangdong Dahua Anti-Peptic Ulcer Drugs Revenue (US$, Mn), (2017-2022)
    Table 57. Xian Janssen Corporate Summary
    Table 58. Xian Janssen Anti-Peptic Ulcer Drugs Product Offerings
    Table 59. Xian Janssen Anti-Peptic Ulcer Drugs Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Anti-Peptic Ulcer Drugs Segment by Type in 2021
    Figure 2. Anti-Peptic Ulcer Drugs Segment by Application in 2021
    Figure 3. Global Anti-Peptic Ulcer Drugs Market Overview: 2020
    Figure 4. Key Caveats
    Figure 5. Global Anti-Peptic Ulcer Drugs Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Anti-Peptic Ulcer Drugs Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Anti-Peptic Ulcer Drugs Revenue in 2021
    Figure 8. By Type - Global Anti-Peptic Ulcer Drugs Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Anti-Peptic Ulcer Drugs Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Anti-Peptic Ulcer Drugs Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Anti-Peptic Ulcer Drugs Revenue Market Share, 2017-2028
    Figure 12. US Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Anti-Peptic Ulcer Drugs Revenue Market Share, 2017-2028
    Figure 16. Germany Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2017-2028
    Figure 17. France Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Anti-Peptic Ulcer Drugs Revenue Market Share, 2017-2028
    Figure 24. China Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2017-2028
    Figure 28. India Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Anti-Peptic Ulcer Drugs Revenue Market Share, 2017-2028
    Figure 30. Brazil Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Anti-Peptic Ulcer Drugs Revenue Market Share, 2017-2028
    Figure 33. Turkey Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2017-2028
    Figure 37. AstraZeneca Anti-Peptic Ulcer Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Ask-pharm Anti-Peptic Ulcer Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Takeda Anti-Peptic Ulcer Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Yangtze River Pharm Anti-Peptic Ulcer Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Shandong Luoxin Anti-Peptic Ulcer Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Huadong Medicine Anti-Peptic Ulcer Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Changzhou Siyao Anti-Peptic Ulcer Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Beijing Yuekang Anti-Peptic Ulcer Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Guangdong Dahua Anti-Peptic Ulcer Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Xian Janssen Anti-Peptic Ulcer Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Anti-Peptic Ulcer Drugs Market In Global report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Anti-Peptic Ulcer Drugs Market In Global report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Anti-Peptic Ulcer Drugs Market In Global report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports